OOIR: Observatory of International Research

Papers

(The median citation count of Endocrine Reviews is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway	542
Endocrine Manifestations and New Developments in Mitochondrial Disease	297
Papillary Craniopharyngioma: An Integrative and Comprehensive Review	261
Correction to: “ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics”	236
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention	220
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies	204
Medical Treatment of Acromegaly: Navigating the Present, Shaping the Future	202
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases	195
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes	185
The Molecular Biology of Midgut Neuroendocrine Neoplasms	178
Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing’s Syndrome	148
A Critical Assessment of Fasting to Promote Metabolic Health and Longevity	144
The Pregnancy-Associated Plasma Protein-A (PAPP-A) Story	130
Correction to: “The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty”	110
Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies	110
Stem Cells and Organs-on-chips: New Promising Technologies for Human Infertility Treatment	101
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?	96
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors	96
The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism	95
The Biology and Clinical Implications of PCSK7	86
Post-translational Modifications: The Signals at the Intersection of Exercise, Glucose Uptake, and Insulin Sensitivity	82
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status	81
Estrogen Receptor Signaling in the Immune System	78
New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature	72
Erratum to: “The Relationship Between Bone and Reproductive Hormones Beyond Estrogens and Androgens”	69

Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas	67
Time-restricted Eating for the Prevention and Management of Metabolic Diseases	62
Contemporary Biological Insights and Clinical Management of Craniopharyngioma	62
Correction to: “Imaging of Pheochromocytomas and Paragangliomas”	61
The Metabolic Role and Therapeutic Potential of the Microbiome	61
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance	59
Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review	58
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia	56
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction	55
Adiponectin and Adiponectin Receptors in Atherosclerosis	55
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling	54
Imaging of Pheochromocytomas and Paragangliomas	52
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease	52
The Cortisol Awakening Response: Regulation and Functional Significance	50
International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood	48
Molecular and Clinical Spectrum of Primary Hyperparathyroidism	47
Brown Adipose Tissue—A Translational Perspective	45
Hippo Signaling in the Ovary: Emerging Roles in Development, Fertility, and Disease	43
Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications	43
Erratum to: Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment	42
G-protein coupled & membrane tyrosine kinase receptors relationship yield therapy opportunities	42
A Modern Approach to Dyslipidemia	41
The Impact of Estrogen Deficiency on Liver Metabolism: Implications for Hormone Replacement Therapy	41
Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease	40
Endocrine Controls of Skin Aging	40
Protective Factors and the Pathogenesis of Complications in Diabetes	39
Medullary Thyroid Cancer: Updates and Challenges	39
Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors	37
Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management	36
Epidemiology, Genetic Etiology, and Intervention of Premature Ovarian Insufficiency	35
Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification	34
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?	32
Teprotumumab for the Treatment of Thyroid Eye Disease	30
Molecular Landscape and Therapeutic Strategies in Pediatric Differentiated Thyroid Carcinoma	30
The Role of Iodine for Thyroid Function in Lactating Women and Infants	30
Clinical, Pathophysiologic, Genetic, and Therapeutic Progress in Primary Bilateral Macronodular Adrenal Hyperplasia	29
Corrigendum to: Personalized Management of Pheochromocytoma and Paraganglioma	29
The Hypothalamus-pituitary-adrenocortical Response to Critical Illness: A Concept in Need of Revision	28
Update on Adipose Tissue and Cancer	28
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement	28
Crosstalk Between the Neuroendocrine System and Bone Homeostasis	28
Molecular Mechanisms of PTH/PTHrP Class B GPCR Signaling and Pharmacological Implications	27
A Clinical Update on Gestational Diabetes Mellitus	26
Corrigendum to: The Role of Iodine for Thyroid Function in Lactating Women and Infants	26
Innovative molecules and delivery technologies enabling the future of GLP-1-based therapies	24
Corrigendum to: Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment	24
Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy	22
The Roles of Natural Killer Cells in Breast Cancer Pathobiology and Their Regulation by Estrogens	22
Endocrine Dysfunction in Primary Mitochondrial Diseases	21
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice	21

Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease	20
Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome	20
Opposing Metabolic Effects of Growth Hormone and IGF-I: Review and Clinical Implications	20
Obesity and Exercise: New Insights and Perspectives	18
Intracellular to Interorgan Mitochondrial Communication in Striated Muscle in Health and Disease	18
Peptidergic G Protein–Coupled Receptor Regulation of Adrenal Function: Bench to Bedside and Back	18
Neurodevelopmental Programming of Adiposity: Contributions to Obesity Risk	18